Health Tech Capitol | Tom Still: Exact Sciences plan to acquire California cancer-fighting firm elevates state’s image
16834
post-template-default,single,single-post,postid-16834,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Tom Still: Exact Sciences plan to acquire California cancer-fighting firm elevates state’s image

04 Aug Tom Still: Exact Sciences plan to acquire California cancer-fighting firm elevates state’s image

Posted at 11:20h in Uncategorized by
0 Likes

In the not-so-distant past, the preferred exit ramp for young health-tech companies in Wisconsin was to be purchased by a bigger firm in California or elsewhere.

The planned acquisition of Genomic Health by Madison-based Exact Sciences Corp. has altered that pattern, with intriguing possibilities for the combined company, Wisconsin’s status as a health-tech leader and, most important, the fight against cancer.

Exact Sciences is coming off a robust quarter in which its DNA-based testing kit for colorectal cancer, Cologuard, was used to screen 415,000 customers and sales generated just under $200 million in revenue. On the same day those figures hit the markets, Exact Sciences jointly announced the $2.8 billion Genomics Health deal.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.